TrialInternational journal of clinical oncology2026

Encorafenib plus binimetinib for BRAF V600-mutated thyroid cancer in Japan: final analysis.

Iwao Sugitani et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.